Breaking News

Euprotec Names Operations Director

January 18, 2013

Thommes to head infectious disease research growth

Dr. Pia Thommes has been appointed scientific operations director at Euprotec, a UK-based CRO. Dr. Thommes will lead Euprotec’s anti-viral area of research and further develop its portfolio of infectious disease biology services.
 
She joins the company from AstraZeneca, where she was associate director in the oncology department. She has 15 years of experience and held increasingly senior positions with large pharmaceutical companies, including GlaxoSmithKline, where she has been involved in numerous anti-viral discovery programs.
 
Lloyd Payne, chief executive of Euprotec said, “Pia brings a wealth of experience and profound knowledge to the team and will be a huge asset to the company as we enter an exciting phase of expansion. We are certain that she will help drive our growth and assist in our mission to position Euprotec as a globally recognized center of excellence for anti-infective drug development.”
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer